Ivermectin, Fenbendazole & Mebendazole — An Educational Guide
Repurposed Cancer Protocols by Richard Harlan — an evidence-based educational guide to the published research on ivermectin, fenbendazole and mebendazole in oncology. Every claim cited to peer-reviewed sources.
Repurposed Cancer Protocols is a plain-language educational guide to the fast-growing body of peer-reviewed literature on three repurposed antiparasitic compounds — ivermectin, fenbendazole and mebendazole — and the laboratory and clinical research examining them in oncology contexts. It is written for informed adults who want to understand what the science says about these repurposed drugs, without hype and without dismissal.
Every claim in the book is traceable to a primary, publicly accessible source: peer-reviewed journals, clinical-trial registries such as ClinicalTrials.gov, and government health databases. The guide does not diagnose, prescribe, or recommend any treatment. It translates dense biochemistry into readable summaries so you can evaluate the evidence for yourself and discuss it intelligently with a qualified physician.
Whether your interest in fenbendazole for cancer, the ivermectin protocol, or repurposed-drug oncology is personal or academic, this guide gives you an honest, citation-heavy map of the current evidence so you can make informed decisions and fight cancer misinformation with facts.
This is the rarest kind of book on this subject: one that neither promotes nor dismisses. Repurposed Cancer Protocols surveys the published literature on ivermectin, fenbendazole and mebendazole in oncology contexts and reports what it actually contains — including, prominently, what it does not contain. Harlan is explicit that no human efficacy has been established and that nothing in the book substitutes for an oncologist. What it offers instead is a map: what has been studied, at what stage, with what result, and how a non-specialist can locate and read those sources without a filter. For readers drowning in confident claims from both directions, the value is precisely the refusal to make one.
— Editorial assessment, The Information Station
The guide leads with the fact that no human efficacy has been established for these compounds in cancer treatment, and that no regulator has approved them for that use. Everything that follows is framed by that.
Claims trace to published journals, clinical-trial registries, and government health databases — not to forums, anecdotes, or influencer summaries.
Ivermectin, fenbendazole and mebendazole are routinely conflated online despite differing in chemistry, approval status, and depth of evidence. The book separates them and explains why the distinction matters.
A recurring emphasis: how to find a study, read its methods, and understand the gap between a mechanistic finding, an animal result, a case report, and a proven human outcome.
Readers are shown how to locate registered trials themselves — and how to tell the difference between a trial being registered, completed, and producing a positive result.
Rather than ignoring the anecdote that drove this topic's popularity, the book examines it and asks what evidentiary weight a single widely-shared story can carry.
Documented safety signals, drug interactions, and contraindications from the literature are presented alongside the mechanisms — not buried.
The stated purpose is to equip a reader to discuss the published research intelligently with a qualified oncologist, not to bypass one.
Read the book? Your honest review helps other readers find it.
All Editorial Reviews →No. There is currently no proven human efficacy for fenbendazole as a cancer treatment, and no regulator has approved it for that use. What exists is a body of laboratory research, animal studies, and a small number of published case reports that have prompted scientific interest. Repurposed Cancer Protocols lays out exactly what that literature does and does not demonstrate, so you can see the evidence for yourself rather than relying on either hype or dismissal.
All three are antiparasitic compounds, but they differ in chemistry, approved uses, and the research base behind them. Mebendazole is approved for human use and has the largest body of oncology-related clinical literature; fenbendazole is a veterinary compound and its human research is far thinner; ivermectin is human-approved for parasitic infection with a separate line of laboratory research. The guide covers each compound's mechanism, evidence base, and safety profile separately.
Yes — several are registered, and the guide explains how to find and read them yourself on ClinicalTrials.gov. It also explains the crucial difference between a trial being registered, a trial being completed, and a trial producing a positive result. Many people conflate the three.
No. It is an educational summary of publicly available scientific literature. It does not diagnose, prescribe, or recommend any treatment, and it is not a substitute for a qualified oncologist. Its purpose is to help you understand the published research well enough to have an informed conversation with your doctor.
The Joe Tippens protocol is a widely circulated regimen that popularised fenbendazole online. The guide addresses it directly — what it consists of, why it spread, and what evidentiary weight a single widely-shared anecdote can and cannot carry.
